Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Cetuximab × Plasma cell × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 67 Head & Neck 41 Thoracic 10 Tumor-Agnostic 7 Gynecologic 4 CNS 4 Breast 2 Sarcoma 1 Plasma cell 1 Other solid neoplasm 1 Genitourinary 1 Dermatologic 1

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 113 Bortezomib 63 Cyclophosphamide 50 Lenalidomide 46 Calcium Dobesilate 46 Melphalan 37 pomalidomide 36 fludarabine 27 Filgrastim 26 fludarabine phosphate 22 carfilzomib 22 daratumumab 20 Granulocyte Colony-Stimulating Factor 17 Whole-Body Irradiation 16 Mycophenolic Acid 15 Antilymphocyte Serum 15 dexamethasone acetate 14 Tacrolimus 14 Thalidomide 13 Busulfan 13 Radiotherapy 12 Peripheral Blood Stem Cell Transplantation 12 Cyclosporine 12 dexamethasone 21-phosphate 10 auricularum 10 pembrolizumab 9 ixazomib 9 Stem Cell Transplantation 9 Rituximab 9 Etoposide 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00368121 2012-07-13

EMMA-1

University of Cologne

Phase 2 Terminated

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡